U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915323) titled 'PET Imaging of the sigma1 Receptor in Healthy Adults' on Oct. 28.
Brief Summary: Evaluate (S)-[18F]FBFP and (R)-[18F]FBFP, sigma-1 radiotracers, in humans, to characterize their pharmacokinetic, metabolic, and in vivo binding profiles, assess feasibility for quantitative kinetic modeling analysis of imaging data, and determine the reliability and reproducibility of kinetic and binding parameters.
Assess specific binding levels of (S)-[18F]FBFP or (R)-[18F]FBFP by conducting test-block studies in humans.
Study Start Date: Oct. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Healthy Control Subjects
Intervention:
DRUG: (S)-[18F] ...